← Leaderboards
Sergey S Shevkoplyas
Tulane University Of Louisiana
$4,203,381
Attributed
$4,550,092
Total exposure
4
Grants
3
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $693.4K · FY2012–25$1M$750K$500K$250K$0
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$4,550,092 · 4
By mechanism
R01$4,129,342 · 3
R21$420,750 · 1
Top collaborators
- Fong Wilson Lam1 shared
Others in their field
Top investigators on “Design”
- Lawrence Corey · Fred Hutchinson Cancer Center$736,542,541
- Sonia M Thomas · Research Triangle Institute$700,865,642
- Tracy L Nolen · Research Triangle Institute$474,487,152
- David Heimbrook · Leidos Biomedical Research, Inc.$460,267,569
- Jeffrey P Krischer · University Of South Florida$427,700,530
- David R. Weir · University Of Michigan At Ann Arbor$385,316,144
Research focus
DesignFiltrationDevicesPerformanceCellsWhole BloodPrototypePlasmaIn VivoExcisionProceduresBloodBaseMicrofluidic MicrochipsPropertyCell InjuryHuman SubjectErythrocytesHematocrit ProcedureInfectionMorphologyHematologyHemoglobinSuspensions
Grant awards (12)
Purifying platelets with high-throughput microfluidics for pediatric and neonatal transfusions$693,423
R01 · FY2025 · HL
Enabling pediatric leukapheresis with high-throughput microfluidic technology$389,600
R01 · FY2023 · HL · contact PI
Enabling pediatric leukapheresis with high-throughput microfluidic technology$389,600
R01 · FY2022 · HL · contact PI
Enabling pediatric leukapheresis with high-throughput microfluidic technology$389,600
R01 · FY2021 · HL · contact PI
Centrifugation-free washing and volume-reduction of platelet concentrate units using high-throughput microfluidic technology$229,500
R21 · FY2021 · HL · contact PI
Enabling pediatric leukapheresis with high-throughput microfluidic technology$402,800
R01 · FY2020 · HL · contact PI
Centrifugation-free washing and volume-reduction of platelet concentrate units using high-throughput microfluidic technology$191,250
R21 · FY2020 · HL · contact PI
Eliminating Mediators of Toxicity from Stored Blood$376,250
R01 · FY2017 · HL · contact PI
Eliminating Mediators of Toxicity from Stored Blood$376,250
R01 · FY2016 · HL · contact PI
Eliminating Mediators of Toxicity from Stored Blood$370,606
R01 · FY2015 · HL · contact PI
Eliminating Mediators of Toxicity from Stored Blood$364,963
R01 · FY2013 · HL · contact PI
Eliminating Mediators of Toxicity from Stored Blood$376,250
R01 · FY2012 · HL · contact PI